1H25 showed management actively managed its lease portfolio with ownerships changed. Also, its 1Q25 trading update was good with projects progressing well with two large FPSOs started in 1H25 and another one probably in 3Q25. On the back of 1Q25 the outlook for 1H25 looks strong and we should not be surprised on a guidance raise for its FY25 EBITDA. Profitability is fine, cash flow is OK, but we do not expect an additional share buyback as last year when reporting 1H25 as they already doubled th...
Voltalia SA: Total number of shares and voting rights in the share capital as of June 30, 2025 Total number of shares and voting rights in the share capital as of June 30, 2025 (Articles L. 233-8 (II) of the French Commercial Code and 223-16 of the General Regulations of the French Financial Markets Authority) Date Total number of shares in the capital Number of theoretical voting rights Number of exercisable voting rights 06/30/2025 131 318 716220 406 383219 988 392 Next on the agenda: Q2 2025 Turnover, July 23, 2025 (after market close) About Voltalia ()Voltalia is an international pl...
Voltalia SA : Nombre total de droits de vote et d’actions composant le capital en date du 30 juin 2025 Nombre total de droits de vote et d’actions composant le capital en date du 30 juin 2025 (Art. L. 233-8 (II) du Code de Commerce et Art. 223-16 du Règlement Général de l’AMF) Date Nombre d’actions composant le capital Nombre de droits de vote théoriques Nombre de droits de vote exerçables 30/06/2025 131 318 716220 406 383219 988 392 Prochain rendez-vous : Chiffre d’affaires du 2ème trimestre 2025, le 23 juillet 2025 (après Bourse) A propos de Voltalia ()Voltalia est un acteur internation...
Weekly share repurchase program transaction details Amsterdam, July 9, 2025 SBM Offshore reports the transaction details related to its EUR141 million (c. US$150 million1) share repurchase program for the period July 3, 2025 through July 9, 2025. The repurchases were made under the EUR141 million share repurchase program announced on February 20, 2025 and effective from April 24, 2025. The objective of the program is to reduce share capital and, in addition, to provide shares for regular management and employee share programs. Information regarding the progress of the share repurchase pr...
Transgene Appoints Seasoned Industry Executive Emmanuelle Quilès to Board of Directors as Independent Director Strasbourg, France, July 9, 2025, 5:45 p.m. CET — Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced the appointment of Emmanuelle Quilès as an independent Director to its Board of Directors. She succeeds Philippe Archinard, who is retiring from the Board. Emmanuelle Quilès brings more than 25 years of experience in strategic leadership roles across the global pharmaceutical industry...
Transgene nomme une experte de l’industrie pharmaceutique, Emmanuelle Quilès, en tant qu’administratrice indépendante au Conseil d’administration Strasbourg, France, 9 juillet 2025, 17 h 45 CET — Transgene (Euronext Paris : TNG), société de biotechnologie qui conçoit et développe des immunothérapies reposant sur des vecteurs viraux contre les cancers, annonce la nomination d’Emmanuelle Quilès en tant qu’administratrice indépendante au sein du Conseil d’administration. Elle succède à Philippe Archinard qui a souhaité quitter le Conseil. Emmanuelle Quilès possède plus de 25 ans d’expérience...
Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of June 30, 2025 Strasbourg, July 8, 2025 – 06:00 pm CET Under the liquidity contract entrusted by Transgene to Natixis Oddo BHF SCA, as of June 30, 2025, the following resources were managed through the liquidity account: 327 750 shares€ 112,376 In the first half of 2025, it was negotiated a total of: Purchases249,004 shares€ 180,297769 market transactionsSales280,915 shares€ 212,020967 market transactions It is recalled that: as of December 31, 2024, the following resources were managed through the liquidity acc...
Bilan du Contrat de Liquidité avec la Société Natixis Oddo BHF SCA au 30 juin 2025 Strasbourg, le 8 juillet 2025 – 18h00 Au titre du contrat de liquidité confié par Transgene à Natixis Oddo BHF SCA, à la date du 30 juin 2025, les moyens suivants figuraient au compte de liquidité : 327 750 titres Transgene112 376 € Au cours du premier semestre 2025, il a été négocié un total de : Achat249 004 titres180 297 €769 transactionsVente280 915 titres212 020 €967 transactions Il est rappelé : que lors du dernier bilan du 31 décembre 2024, les moyens suivants figuraient au compte de liquidité : ...
Voltalia SA: Half-year statement of the liquidity contract as of June 30, 2025 Half-year statement of the liquidity contract As of June 30, 2025 Voltalia (Euronext Paris, ISIN code: FR0011995588), announces that the Company’s liquidity account, which is managed by NATEXIS ODDO BHF under a liquidity contract, included the following cash and Company common shares as of June 30, 2025: 32,669 shares €697,040Number of transactions on buy side over the period: 2,715Number of transactions on sell side over the period: 2,851Volume traded on buy side over the period: 597,704 shares for €4,583,68...
Voltalia SA : Bilan semestriel du contrat de liquidité au 30 juin 2025 Bilan semestriel du contrat de liquidité Au 30 juin 2025 Voltalia (Euronext Paris, code ISIN : FR0011995588), annonce qu’au titre du contrat de liquidité confié par la Société à NATIXIS ODDO BHF, les moyens suivants figuraient au compte de liquidité à la date du 30 juin 2025 : 32 669 titres697 040 euros Nombre de transactions exécutées sur le semestre à l'achat : 2 715Nombre de transactions exécutées sur le semestre à la vente : 2 851Volume échangé sur le semestre à l'achat : 597 704 titres pour 4 583 680 eur...
La surperformance des Small&Midcaps au S1 reste marquée par un contexte de i/ momentum sans dynamique haussière (sauf peut-être en Italie ou en Espagne), alors que les devises impacteront T2&T3, ii/ géopolitique instable, iii/ fébrilité : les 2 plus grandes puissances économiques (Chine et USA) sont en phase de pivot et/ou présentent certaines fragilités, iv/ valorisations toujours attractives (décote de 30% par rapport aux large caps, et multiples sous leurs niveaux historiques). Nous sommes ra...
The outperformance of small and mid caps in H1 was marked by i/ the absence of upward revision momentum (except perhaps in Italy and Spain), while forex effects are set to dent Q2 and Q3, ii/ geopolitical turmoil, iii/ a jittery market: the two biggest economic powers (China and the US) are in a period of transition and/or showing signs of weakness, iv/ attractive valuations (30% discount to large caps and multiples below historical levels). We are reasonably optimistic about small and mid caps ...
Weekly share repurchase program transaction details Amsterdam, July 2, 2025 SBM Offshore reports the transaction details related to its EUR141 million (c. US$150 million1) share repurchase program for the period June 26, 2025 through July 2, 2025. The repurchases were made under the EUR141 million share repurchase program announced on February 20, 2025 and effective from April 24, 2025. The objective of the program is to reduce share capital and, in addition, to provide shares for regular management and employee share programs. Information regarding the progress of the share repurchase p...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.